Lindsay Goldberg recapitalized MMS

Jun. 2022

Client: Lindsay Goldberg is an American private equity firm focused on leveraged buyout and growth capital investments in middle-market companies

Role: Edgemont Partners acted as exclusive financial advisor to Lindsay Goldberg on its recapitalization of MMS, a data-focused CRO servicing the pharmaceutical, biotech, and medical device industry via the provision of regulatory, biostatistics, data management, medical writing, and pharmacovigilance services throughout the clinical trial process

Location: Canton, MI

Sector: Pharmaceutical Services

Lead Banker: David Blume

View Press Release